Bipolar Disorder: Clinical Trials

4 trials for Bipolar Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 active not recruiting. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Active not recruiting 4
Phase 21Active not recruiting 1

Follow Bipolar Disorder: new trials by email Literature Review of Bipolar Disorder trials Research Report on Bipolar Disorder

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
Azetukalner - Bipolar Depression, Bipolar I Disorder
Phase 3Active not recruitingXenon Pharmaceuticals Inc.4002025-10-302026-10-13
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
Azetukalner, Placebo - Bipolar Disorder, Bipolar Depression
Phase 3Active not recruitingXenon Pharmaceuticals Inc.4002025-08-082026-10-13
Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy
Sigma-Stim, RUL LAP-ST (Low-Amplitude Pulse Seizure Therapy - Right Unilateral) - Suicidal Ideation, Major Depressive Disorder
Phase 2 / Phase 3Active not recruitingMichigan State University302024-07-032026-11-02
Predictors of Intravenous Ketamine Response in TRD
Ketamine, Midazolam - Treatment Resistant Depression, Major Depressive Disorder
Phase 3Active not recruitingAbraham Nunes402024-01-192026-05-22

Narrower conditions

Depressive Disorder, Major (2)  ·  Depression (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Psychotic Disorders (1)  ·  Suicidal Ideation (1)  ·  Suicide (1)

Broader conditions

Bipolar and Related Disorders (4)  ·  Mental Disorders (4)  ·  Mood Disorders (4)  ·  Depressive Disorder (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)  ·  Self-Injurious Behavior (1)

Interventions

Ketamine (1)  ·  Midazolam (1)  ·  XEN1101 (1)

Sponsors

Xenon Pharmaceuticals Inc. (2)  ·  Abraham Nunes (1)  ·  Michigan State University (1)

Countries

United States (3)  ·  Bulgaria (1)  ·  Canada (1)  ·  Germany (1)  ·  Spain (1)

Top investigators

Abraham Nunes, MD PhD MBA FRCPC (1)  ·  Nagy A Youssef, MD, PhD (1)